CTMX
CytomX Therapeutics Inc.
Company Overview
| Mkt Cap | $326.53M | Price | $3.57 |
| Volume | 2.77M | Change | +7.21% |
| P/E Ratio | 10.2 | Open | $3.38 |
| Revenue | $138.1M | Prev Close | $3.33 |
| Net Income | $31.9M | 52W Range | $0.40 - $3.91 |
| Div Yield | N/A | Target | $6.14 |
| Overall | 67 | Value | 80 |
| Quality | 42 | Technical | 81 |
No chart data available
Stock Overview
Updated DailyCytomX Therapeutics Inc. (CTMX) is a leading Healthcare company in the Biotechnology industry, currently trading at $3.57 with a market capitalization of $326.53 million. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows CTMX with a volume of 2.77 million shares. The stock opened up 1.50% from yesterday's close of $3.33. Current analyst estimates project earnings of $0.05 per share for this year, with next year targeting $-0.29.
CTMX demonstrates positive technical signals based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for CTMX include strong overall investment metrics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 72.0%. The stock shows attractive valuation opportunity based on valuation analysis.
Analysis generated on November 2, 2025 at 10:32 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CTMX | $3.57 | +7.2% | 2.77M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get CytomX Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW